Biogen/ US09062X1037 /
| 2024-04-19 9:25:18 PM | Chg. +2.71 | Volume | Bid9:25:18 PM | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 193.26USD | +1.42% | 40,785 Turnover: 7.81 mill. |
189.50Bid Size: 101 | -Ask Size: - | 27.97 bill.USD | - | 24.00 |
Assets
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 1,641.6000 | 1,571.4000 | 1,742.2000 | 1,750.7000 | 1,765.6830 | ||||||
| Intangible Assets | 1,772.8000 | 1,608.2000 | 1,631.5000 | 4,474.7000 | 4,028.5070 | ||||||
| Long-Term Investments | 743.1000 | 1,416.7000 | 2,036.7000 | 625.8000 | 1,470.6520 | ||||||
| Fixed Assets | - | - | - | - | 9,643.8860 | ||||||
| Inventories | 289.1000 | 326.8000 | 447.4000 | 659 | 804.0220 | ||||||
| Accounts Receivable | 605.3000 | 584.6000 | 686.8000 | 824.4000 | 1,292.4450 | ||||||
| Cash and Cash Equivalents | 759.6000 | 514.5000 | 570.7000 | 602.6000 | 1,204.9240 | ||||||
| Current Assets | 2,540.4000 | 2,975.4000 | 3,244.3000 | 3,184.9000 | 4,672.6730 | ||||||
| Total Assets | 8,092.5000 | 9,049.6000 | 10,130.1000 | 11,863.3000 | 14,316.5590 | ||||||
Liabilities
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 162.5000 | 186.4000 | 204 | 219.9000 | 229.1780 | ||||||
| Long-term debt | - | - | - | 592.4000 | 582.0610 | ||||||
| Liabilities to Banks | 0.0000 | 0.0000 | 0.0000 | 592.4000 | 582.1000 | ||||||
| Provisions | 285.5000 | 294.5000 | 237.4000 | 412.3000 | 218.8000 | ||||||
| Liabilities | 2,643.2000 | 2,622.6000 | 3,166.3000 | 3,242.5000 | 3,502.5190 | ||||||
| Share Capital | - | - | - | - | .1290 | ||||||
| Total Equity | 5,449.4000 | 6,427 | 6,963.8000 | 8,620.8000 | 10,814.0400 | ||||||
| Minority Interests | 52.9000 | 1.5000 | 2.3000 | .6000 | 5.0300 | ||||||
| Total liabilities equity | 8,092.5000 | 9,049.6000 | 10,130.1000 | 11,863.3000 | 14,316.5590 | ||||||
Income Statement
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 4,716.4000 | 5,048.6000 | 5,516.5000 | 6,932.2000 | 9,703.3240 | ||||||
| Depreciation (total) | 208.9000 | 208.6000 | 202.2000 | 342.9000 | 688.1500 | ||||||
| Operating Result | 1,248.9000 | 1,724.7000 | 1,809.1000 | 2,490.6000 | 3,972.4140 | ||||||
| Interest Income | - | - | - | - | -17.3000 | ||||||
| Income Before Taxes | 1,229.9000 | 1,711.2000 | 1,855.1000 | 2,480.6000 | 3,946.6330 | ||||||
| Income Taxes | 331.3000 | 444.5000 | 470.6000 | 601 | 989.9420 | ||||||
| Minority Interests Profit | 106.7000 | -32.3000 | 0.0000 | 0.0000 | 6.7810 | ||||||
| Net Income | 1,005.3000 | 1,234.4000 | 1,380 | 1,862.3000 | 2,934.7840 | ||||||
Per Share
Cash Flow
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 1,624.7000 | 1,727.7000 | 1,879.9000 | 2,345.1000 | 2,942.1150 | ||||||
| Cash Flow from Investing Activities | 345.3000 | -1,650.3000 | -950.3000 | -1,604.7000 | -1,542.9760 | ||||||
| Cash Flow from Financing | -1,784.9000 | -319.9000 | -877.5000 | -716.5000 | -755.8730 | ||||||
| Decrease / Increase in Cash | 185.1000 | -242.4000 | 52.1000 | 23.9000 | 643.2660 | ||||||
| Employees | 4,850 | 5,000 | 5,950 | 6,850 | 7,550 | ||||||
